| First Author | Babcock RL | Year | 2022 |
| Journal | Mol Immunol | Volume | 148 |
| Pages | 6-17 | PubMed ID | 35640521 |
| Mgi Jnum | J:337174 | Mgi Id | MGI:7295249 |
| Doi | 10.1016/j.molimm.2022.05.009 | Citation | Babcock RL, et al. (2022) Regulation and function of Id2 in plasmacytoid dendritic cells. Mol Immunol 148:6-17 |
| abstractText | Plasmacytoid dendritic cells (pDCs) are specialized type I interferon (IFN-I) producing cells that promote anti-viral immune responses and contribute to autoimmunity. Development of pDCs requires the transcriptional regulator E2-2 and is opposed by inhibitor of DNA binding 2 (Id2). Prior work indicates Id2 is induced in pDCs upon maturation and may affect pDC IFN-I production via suppression of E2-2, suggesting an important yet uncharacterized role in this lineage. We found TLR7 agonists stimulate Id2 mRNA and protein expression in pDCs. We further show that transcriptional activation of Id2 is dependent on the E2 ubiquitin-conjugating enzyme Ubc13, but independent of IFN-I signaling in response to TLR7 agonist stimulation. Nonetheless, conditional Id2 depletion in pDCs indicates Id2 is dispensable for TLR7 agonist-induced maturation and inhibition of E2-2 expression. Thus, we identify new mechanisms of Id2 regulation by Ubc13, which may be relevant for understanding Id2 gene regulation in other contexts, while ruling out major roles for Id2 in pDC responses to TLR7 agonists. |
